N,N-Diethylazetidin-3-amine dihydrochloride

Catalog No.: 
ACXEDQ647
CAS No.: 
149088-16-4
Molecular Formula: 
C7H18Cl2N2
Molecular Weight: 
201.14
N,N-Diethylazetidin-3-amine dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$98.00In stockInquiry
5g95%$327.00In stockInquiry
10g95%$583.00In stockInquiry
25g95%$1336.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,N-Diethylazetidin-3-amine dihydrochloride
IUPAC NameN,N-diethylazetidin-3-amine dihydrochloride
MDL No.MFCD18381080
Molecular FormulaC7H18Cl2N2
Molecular Weight201.14
SMILESCCN(CC)C1CNC1.Cl.Cl
InChI KeyJEKVHMVVZYZMMR-UHFFFAOYSA-N
Synonym3-(N,N-Dimethylamino)azetidine Dihydrochloride;N,N-diethylazetidin-3-amine dihydrochloride;3-Azetidinamine, N,N-diethyl-, dihydrochloride;N,N-diethylazetidin-3-amine 2HCl;3-(Diethylamino)azetidine 2HCl;N,N-diethylazetidin-3-amine dihydrochloride - [D83061]
CAS No.149088-16-4
PubChem CID19423807

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXEDQ647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEDQ647 route product structure diagram
    ACXEDQ647149088-16-4In Stock
Inquiry

2. ACXEDQ647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEDQ647 route product structure diagram
    ACXEDQ647149088-16-4In Stock
Inquiry

3. ACXEDQ647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXEDQ647 route product structure diagram
    ACXEDQ647149088-16-4In Stock
Inquiry

Comments (0)